All Stories

  1. Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials

    Article • The Lancet, December 2024, Elsevier

    Dr. Jordi Barquinero

  2. European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain

    Article • Neuromuscular Disorders, March 2024, Elsevier

    Dr. Jordi Barquinero

  3. Dysbiosis: An Indicator of COVID-19 Severity in Critically Ill Patients

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Dr. Jordi Barquinero

  4. Oxidative Stress in Structural Valve Deterioration: A Longitudinal Clinical Study

    Article • Biomolecules, October 2022, MDPI AG

    Professor Luigi P. Badano, Dr. Jordi Barquinero

  5. Preclinical Assessment of a Gene-Editing Approach in a Mouse Model of Mitochondrial Neurogastrointestinal Encephalomyopathy

    Article • Human Gene Therapy, October 2021, Mary Ann Liebert Inc

    Dr. Jordi Barquinero

  6. Hematopoietic Engraftment of Fanconi Anemia Patients through 3 Years after Gene Therapy

    Article • Blood, November 2019, American Society of Hematology

    Dr. Jordi Barquinero

  7. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia

    Article • Nature Medicine, September 2019, Springer Science + Business Media

    Dr. Jordi Barquinero

  8. Variable readthrough responsiveness of nonsense mutations in hemophilia A

    Article • Haematologica, June 2019, Ferrata Storti Foundation (Haematologica)

    Dr. Jordi Barquinero

  9. Absence of p.R50X Pygm read-through in McArdle disease cellular models

    Article • Disease Models & Mechanisms, January 2019, The Company of Biologists

    Dr. Jordi Barquinero

  10. Expression of microRNA-155 in inflammatory cells modulates liver injury

    Article • Hepatology, May 2018, Wiley

    Dr. Jordi Barquinero

  11. Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA

    Article • Journal of Thrombosis and Haemostasis, September 2017, Wiley

    Dr. Jordi Barquinero

  12. Response of the human myocardium to ischemic injury and preconditioning: The role of cardiac and comorbid conditions, medical treatment, and basal redox status

    Article • PLOS One, April 2017, PLOS

    Dr. Jordi Barquinero

  13. Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes

    Article • Immunology and Cell Biology, February 2017, Wiley

    Dr. Jordi Barquinero

  14. Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis

    Article • Experimental Neurology, December 2016, Elsevier

    Dr. Jordi Barquinero

  15. A reproducible method for the isolation and expansion of ovine mesenchymal stromal cells from bone marrow for use in regenerative medicine preclinical studies

    Article • Journal of Tissue Engineering and Regenerative Medicine, November 2016, Wiley

    Dr. Jordi Barquinero

  16. Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy

    Article • Human Gene Therapy, September 2016, Mary Ann Liebert Inc

    Dr. Jordi Barquinero

  17. Prospective therapeutic approaches in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

    Article • Expert Opinion on Orphan Drugs, September 2015, Informa Healthcare

    Dr. Jordi Barquinero

  18. 279. Efficient and Safe Lentiviral Vector-Mediated Hematopoietic Stem Cell Gene Therapy in MNGIE Mice

    Article • Molecular Therapy, May 2015, Elsevier

    Dr. Jordi Barquinero

  19. Molecular characterization of ten F8 splicing mutations in RNA isolated from patient's leucocytes: assessment of in silico prediction tools accuracy

    Article • Haemophilia, February 2015, Wiley

    Dr. Jordi Barquinero

  20. Hematopoietic chimerisms: friends or foes?

    Article • Advances in Regenerative Biology, September 2014, Taylor & Francis

    Dr. Jordi Barquinero

  21. Thymidine phosphorylase is both a therapeutic and a suicide gene in a murine model of mitochondrial neurogastrointestinal encephalomyopathy

    Article • Gene Therapy, May 2014, Springer Science + Business Media

    Dr. Jordi Barquinero

  22. Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE

    Article • Molecular Therapy, January 2014, Nature

    Dr. Jordi Barquinero

  23. Myeloid-Derived Suppressor Cells Are Generated During Retroviral Transduction of Murine Bone Marrow

    Article • Cell Transplantation, January 2014, Cognizant Communication Corporation

    Dr. Jordi Barquinero

  24. Bone Marrow Transplantation in Dysferlin-Deficient Mice Results in a Mild Functional Improvement

    Article • Stem Cells and Development, November 2013, Mary Ann Liebert Inc

    Dr. Jordi Barquinero

  25. Notch signals contribute to preserve the multipotentiality of human CD34+CD38−CD45RA−CD90+ hematopoietic progenitors by maintaining T cell lineage differentiation potential

    Article • Experimental Hematology, December 2012, Elsevier

    Dr. Jordi Barquinero

  26. Myeloid-derived suppressor cells (MDSC): Another player in the orchestra

    Article • Inmunología, April 2011, Elsevier

    Dr. Jordi Barquinero

  27. Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE

    Article • Gene Therapy, March 2011, Nature

    Dr. Jordi Barquinero

  28. Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response

    Article • Gene Therapy, December 2009, Nature

    Dr. Jordi Barquinero

  29. Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis

    Article • Experimental Cell Research, October 2009, Elsevier

    Dr. Jordi Barquinero

  30. Transgene Expression Levels Determine the Immunogenicity of Transduced Hematopoietic Grafts in Partially Myeloablated Mice

    Article • Molecular Therapy, August 2009, Nature

    Dr. Jordi Barquinero

  31. Bone Marrow Transplantation Induces Normoglycemia in a Type 2 Diabetes Mellitus Murine Model

    Article • Transplantation Proceedings, July 2009, Elsevier

    Dr. Jordi Barquinero

  32. Corrigendum to “Tolerance Induction in Experimental Autoimmune Encephalomyelitis Using Non-myeloablative Hematopoietic Gene Therapy With Autoantigen”

    Article • Molecular Therapy, July 2009, Nature

    Dr. Jordi Barquinero

  33. Tolerance Induction in Experimental Autoimmune Encephalomyelitis Using Non-myeloablative Hematopoietic Gene Therapy With Autoantigen

    Article • Molecular Therapy, March 2009, Nature

    Dr. Jordi Barquinero

  34. The Hoechst low-fluorescent profile of the side population: clonogenicity versus dye retention

    Article • Blood, May 2006, American Society of Hematology

    Dr. Jordi Barquinero

  35. Terapia génica: realidades actuales y expectativas

    Article • Revista Clínica Española, April 2005, Elsevier

    Dr. Jordi Barquinero

  36. Aplicaciones terapéuticas de las células madre

    Article • Medicina Clínica, April 2005, Elsevier

    Dr. Jordi Barquinero

  37. A rare fraction of human hematopoietic stem cells with large telomeres

    Article • Cell and Tissue Research, January 2005, Springer Science + Business Media

    Dr. Jordi Barquinero

  38. Células madre en el tratamiento de la sordera

    Article • Acta Otorrinolaringológica Española, January 2005, Elsevier

    Dr. Jordi Barquinero

  39. Flow cytometry-based approach to ABCG2 function suggests that the transporter differentially handles the influx and efflux of drugs

    Article • Cytometry, October 2004, Wiley

    Dr. Jordi Barquinero

  40. Retroviral vectors: new applications for an old tool

    Article • Gene Therapy, October 2004, Nature

    Dr. Jordi Barquinero

  41. Antiphospholipid antibodies and stroke

    Article • Current Cardiology Reports, March 2004, Springer Science + Business Media

    Dr. Jordi Barquinero

  42. Myeloablation enhances engraftment of transduced murine hematopoietic cells, but does not influence long-term expression of the transgene

    Article • Gene Therapy, October 2002, Nature

    Dr. Jordi Barquinero

  43. Terapia génica en células madre hematopoyéticas: mitos y realidades

    Article • Medicina Clínica, January 2001, Elsevier

    Dr. Jordi Barquinero

  44. Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice

    Article • Blood, May 2000, American Society of Hematology

    Dr. Jordi Barquinero

  45. Highly Efficient Transduction of the Green Fluorescent Protein Gene in Human Umbilical Cord Blood Stem Cells Capable of Cobblestone Formation in Long-Term Cultures and Multilineage Engraftment of Immunodeficient Mice

    Article • Blood, December 1998, American Society of Hematology

    Dr. Jordi Barquinero

  46. High-Titer Retroviral Vectors Containing the Enhanced Green Fluorescent Protein Gene for Efficient Expression in Hematopoietic Cells

    Article • Blood, November 1997, American Society of Hematology

    Dr. Jordi Barquinero

  47. Allogeneic marrow grafts from donors with congenital chromosomal abnormalities in marrow cells

    Article • British Journal of Haematology, July 1995, Wiley

    Dr. Jordi Barquinero

  48. Myelosuppressive conditioning improves autologous engraftment of genetically marked hematopoietic repopulating cells in dogs

    Article • Blood, March 1995, American Society of Hematology

    Dr. Jordi Barquinero

  49. Antibodies Against Platelet-Activating Factor in Patients with Antiphospholipid Antibodies

    Article • Lupus, February 1994, SAGE Publications

    Dr. Jordi Barquinero

  50. Effect of Human IgG Antiphospholipid Antibodies on an In Vivo Thrombosis Model in Mice

    Article • Thrombosis and Haemostasis, January 1994, Thieme Publishing Group

    Dr. Jordi Barquinero

  51. Primary antiphospholipid syndrome

    Article • The American Journal of Medicine, March 1993, Elsevier

    Dr. Jordi Barquinero

  52. Valvular Heart Disease in the Primary Antiphospholipid Syndrome

    Article • Annals of Internal Medicine, February 1992, American College of Physicians

    Dr. Jordi Barquinero

  53. Anticardiolipin antibodies and binding of anionic phospholipids and serum protein

    Article • The Lancet, August 1990, Elsevier

    Dr. Jordi Barquinero

  54. Fetal Loss Treatment in Patients with Antiphospholipid Antibodies

    Article • Obstetrical & Gynecological Survey, May 1990, Wolters Kluwer Health

    Dr. Jordi Barquinero

  55. Polymyositis and cyclosporin A.

    Article • Annals of the Rheumatic Diseases, January 1990, BMJ

    Dr. Jordi Barquinero

  56. Anticorps antiphospholipide et rickettsioses

    Article • La Revue de Médecine Interne, November 1989, Elsevier

    Dr. Jordi Barquinero

  57. The “Primary” Antiphospholipid Syndrome

    Article • Medicine, November 1989, Wolters Kluwer Health

    Dr. Jordi Barquinero

  58. Fetal loss treatment in patients with antiphospholipid antibodies.

    Article • Annals of the Rheumatic Diseases, October 1989, BMJ

    Dr. Jordi Barquinero

  59. Anticardiolipin Antibodies and Migraine-Related Strokes

    Article • Archives of Neurology, June 1988, American Medical Association (AMA)

    Dr. Jordi Barquinero

  60. Sneddon's syndrome and anticardiolipin antibodies.

    Article • Stroke, June 1988, Wolters Kluwer Health

    Dr. Jordi Barquinero

  61. Lupus anticoagulant and portal hypertension

    Article • The American Journal of Medicine, March 1988, Elsevier

    Dr. Jordi Barquinero

  62. Lupus Anticoagulant and Stroke

    Article • Archives of Neurology, July 1987, American Medical Association (AMA)

    Dr. Jordi Barquinero

  63. Serum Thrombocytopenia and High-Dose Immunoglobulin Treatment

    Article • Annals of Internal Medicine, February 1986, American College of Physicians

    Dr. Jordi Barquinero